Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP) and on the impact of the treatment on tumor biology.
Phase of Trial: Phase IV
Latest Information Update: 31 Oct 2017
At a glance
- Drugs Imatinib (Primary)
- Indications Dermatofibrosarcoma
- Focus Pharmacodynamics; Therapeutic Use
- 31 Oct 2017 New trial record